IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v443y2006i7107d10.1038_nature05114.html
   My bibliography  Save this article

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design

Author

Listed:
  • Rupert J. Russell

    (MRC National Institute for Medical Research, The Ridgeway
    University of St Andrews)

  • Lesley F. Haire

    (MRC National Institute for Medical Research, The Ridgeway)

  • David J. Stevens

    (MRC National Institute for Medical Research, The Ridgeway)

  • Patrick J. Collins

    (MRC National Institute for Medical Research, The Ridgeway)

  • Yi Pu Lin

    (MRC National Institute for Medical Research, The Ridgeway)

  • G. Michael Blackburn

    (University of Sheffield)

  • Alan J. Hay

    (MRC National Institute for Medical Research, The Ridgeway)

  • Steven J. Gamblin

    (MRC National Institute for Medical Research, The Ridgeway)

  • John J. Skehel

    (MRC National Institute for Medical Research, The Ridgeway)

Abstract

The worldwide spread of H5N1 avian influenza has raised concerns that this virus might acquire the ability to pass readily among humans and cause a pandemic. Two anti-influenza drugs currently being used to treat infected patients are oseltamivir (Tamiflu) and zanamivir (Relenza), both of which target the neuraminidase enzyme of the virus. Reports of the emergence of drug resistance make the development of new anti-influenza molecules a priority. Neuraminidases from influenza type A viruses form two genetically distinct groups: group-1 contains the N1 neuraminidase of the H5N1 avian virus and group-2 contains the N2 and N9 enzymes used for the structure-based design of current drugs. Here we show by X-ray crystallography that these two groups are structurally distinct. Group-1 neuraminidases contain a cavity adjacent to their active sites that closes on ligand binding. Our analysis suggests that it may be possible to exploit the size and location of the group-1 cavity to develop new anti-influenza drugs.

Suggested Citation

  • Rupert J. Russell & Lesley F. Haire & David J. Stevens & Patrick J. Collins & Yi Pu Lin & G. Michael Blackburn & Alan J. Hay & Steven J. Gamblin & John J. Skehel, 2006. "The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design," Nature, Nature, vol. 443(7107), pages 45-49, September.
  • Handle: RePEc:nat:nature:v:443:y:2006:i:7107:d:10.1038_nature05114
    DOI: 10.1038/nature05114
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature05114
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature05114?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Kyle T Greenway & Eric B LeGresley & B Mario Pinto, 2013. "The Influence of 150-Cavity Binders on the Dynamics of Influenza A Neuraminidases as Revealed by Molecular Dynamics Simulations and Combined Clustering," PLOS ONE, Public Library of Science, vol. 8(3), pages 1-15, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:443:y:2006:i:7107:d:10.1038_nature05114. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.